It does not sell or prescribe medication; instead, it reviews programs offering compounded and brand-name semaglutide and tirzepatide, including options involving Wegovy, Ozempic, Zepbound, and Mounjaro.

The site ranks programs using verified prices, transparency, and safety checks. Prices are re-checked weekly against live checkouts, with intake fees and required add-ons included. Its reviews also record pharmacy and prescriber details, treatment availability by state, and relevant FDA, accreditation, and other verification information. Programs with an open FDA warning letter are excluded from recommendations, and commissions do not affect scores or rankings.

Visitors can compare programs by medication, price, and availability, read individual program reviews, and explore cost and coverage resources, including CMS pharmacy acquisition data. Educational guides cover medication comparisons, dosing, injections, side effects, insurance, and compounded products. The site emphasizes that its information is educational, not medical advice, and recommends consulting a licensed clinician about treatment.